WM
WASTE MANAGEMENT INC (WM)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 delivered mixed headline results: EPS beat, while revenue and EBITDA were modestly below consensus; underlying legacy margins remained strong at 30.0% adjusted, for the fourth consecutive quarter, despite winter weather and the expiration of alternative fuel tax credits .
- Reported revenue was $6.018B (+16.7% YoY), adjusted operating EBITDA $1.715B (+12.2% YoY), and adjusted EPS $1.67; EPS beat consensus by ~$0.08, while revenue and EBITDA modestly missed Street .
- WM Healthcare Solutions (Stericycle) contributed $619M revenue and $95M adjusted EBITDA, with $16M synergies recognized; management clarified 2025 synergy range at $80–$100M with a $90M midpoint and reaffirmed a $250M run-rate by 2027 .
- 2025 outlook reaffirmed: adjusted operating EBITDA $7.45–$7.65B, free cash flow $2.675–$2.775B, core price 5.8–6.2%, volumes 0.25–0.75%; tuck-in acquisition revenue outlook raised to $80–$125M (from $35–$80M), and RNG offtakes locked increased to ~75% for 2025 .
- Stock reaction catalysts: accelerating synergy capture in 2H 2025, stronger RNG volumes/pricing with hedged offtakes, residential margin improvement, and June Investor Day narrative updates .
What Went Well and What Went Wrong
What Went Well
- Legacy business adjusted EBITDA grew 6% YoY and achieved 30% margin for the fourth straight quarter; margin expansion was driven by price-cost spread and recycling automation (+20 bps), offsetting the 30 bps headwind from alternative fuel tax credit expiration .
- Sustainability businesses delivered: recycling and renewable energy combined operating EBITDA grew >20% YoY; automated recycling facilities delivered nearly 2x margins vs. non-automated; multiple RNG plants were brought online with strong pricing for natural gas and renewable electricity .
- Healthcare Solutions integration advancing: $95M adjusted EBITDA in Q1, $16M synergies realized, divestiture of Spain/Portugal completed to refocus portfolio; management reiterated confidence in $80–$100M synergies in 2025 and $250M run-rate by 2027 .
- Quote: “We’re on track to achieve $250 million of annual run rate synergies in 2027” — Jim Fish .
What Went Wrong
- EPS strength contrasted with modest revenue and EBITDA shortfalls vs consensus; total company adjusted EBITDA margin fell 110 bps YoY to 28.5%, largely due to WM Healthcare Solutions’ lower margin mix .
- Weather and mix headwinds: winter weather reduced volume by ~30 bps; industrial temporary roll-off softness and unexpected national account bankruptcies pressured yield conversion despite strong core price .
- SG&A percentage rose at the total company level on consolidation of Healthcare Solutions, though sequential improvement was achieved; disposal and fleet costs muted Stericycle margin expansion despite 70 bps SG&A improvement QoQ .
Financial Results
Quarterly Performance (oldest → newest)
Year-over-Year Comparison (Q1 2024 vs Q1 2025)
Actual vs. Consensus (Q1 2025)
Values with an asterisk are from S&P Global; Values retrieved from S&P Global.
- Result: EPS beat, Revenue miss, EBITDA miss.
Segment Breakdown (Q1 2025)
KPIs (Q1 2025)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- Strategy and performance: “We had a strong start to the year with first quarter results exceeding our expectations on several fronts… our momentum… gives us confidence in our ability to achieve all of our financial guidance” — Jim Fish .
- Sustainability investments: “Automated recycling facilities delivered nearly double the operating EBITDA margin compared to our nonautomated facilities… 7 more next‑gen recycling plants scheduled to come in 2025” — Jim Fish .
- Healthcare synergies: “We’re on track to achieve $250 million of annual run rate synergies in 2027” — Jim Fish .
- Margin drivers: “Legacy business achieved 30% margin… a 50 bps contribution from favorable price‑to‑cost spread… 20 bps from recycling automation… offset by 30 bps headwind from alternative fuel tax credit” — Devina Rankin .
- Outlook clarity: “We remain confident… operating EBITDA of between $7.45 billion and $7.65 billion” — John Morris .
Q&A Highlights
- Seasonality and margin outlook: Management expects normal seasonal margin uptick in Q2, strongest margins in Q3; base business margin expansion of ~100 bps YoY (price‑cost + automation) with Healthcare synergy ramp through 2H .
- Yield vs core price: Strong core price across lines; yield conversion pressured by mix (industrial temporary softness, wildfire special waste), weather, and bankruptcies in national accounts; sequential improvement expected .
- Healthcare synergies: ~$16M captured in Q1; 2025 synergy range $80–$100M with $90M midpoint; actions include SG&A rationalization, ERP optimization, fleet/disposal internalization ramping in 2H .
- RNG/recycling trajectory and tariffs: Tracking plan for ~$190M YoY sustainability growth contributions; no tariff‑related delays or capex increases expected; 75% RNG volumes locked, reducing RIN price sensitivity to ~$5M per $0.25 .
- M&A pipeline: Solid waste tuck‑ins raised to ~$500M for 2025, with incremental revenue of ~$80–$125M now contemplated vs ~$35–$80M prior .
Estimates Context
- Q1 2025 EPS beat: $1.67 vs consensus $1.586*; revenue miss: $6.018B vs $6.105B*; EBITDA miss: $1.684B vs $1.708B* .
- Implications: Legacy margin strength and pricing discipline support EPS beat; weather/mix headwinds and Healthcare margin mix explain modest revenue/EBITDA shortfalls; consensus may edge higher on synergy clarity and hedge‑backed RNG derisking .
Values retrieved from S&P Global.
Key Takeaways for Investors
- Pricing power and cost discipline continue to expand legacy margins, underpinning EPS resilience even with mix/weather headwinds .
- EPS beat vs consensus with revenue and EBITDA modest misses; legacy trend remains intact while Healthcare integration dilutes margin but is ramping synergies .
- Healthcare synergy capture accelerates in 2H (ERP, SG&A, fleet/disposal internalization), a catalyst for margin uplift and multiple support .
- RNG volumes and pricing are better protected with ~75% offtakes locked, reducing commodity sensitivity and supporting sustainability EBITDA trajectory .
- Residential line margin now ~20%; continued shedding of low‑margin volume and tech adoption should sustain margin mix improvement through 2025/early 2026 .
- Raised tuck‑in acquisition outlook ($80–$125M revenue) and ongoing pipeline should bolster inorganic growth and network advantages .
- Near‑term focus: monitor Q2 seasonality recovery post‑weather, Healthcare margin progression, sustainability project commissioning cadence, and detailed long‑term targets at June Investor Day .